These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3063340)

  • 1. The Wisconsin Tamoxifen Study: toxicity in node-negative postmenopausal women.
    Love RR
    Cancer Invest; 1988; 6(5):601-5. PubMed ID: 3063340
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant tamoxifen treatment of elderly women with stage II breast cancer. A double-blind comparison with placebo.
    Cummings FJ; Gray R; Davis TE; Tormey DC; Harris JE; Falkson G; Arseneau J
    Ann Intern Med; 1985 Sep; 103(3):324-9. PubMed ID: 3896085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.
    Stewart HJ; Forrest AP; Gunn JM; Hamilton T; Langlands AO; McFadyen IJ; Roberts MM
    Eur J Cancer (1965); 1980; Suppl 1():83-8. PubMed ID: 7032945
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
    Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
    Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
    Taylor SG; Kalish LA; Olson JE; Cummings F; Bennett JM; Falkson G; Tormey DC; Carbone PP
    J Clin Oncol; 1985 Feb; 3(2):144-54. PubMed ID: 3881561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.
    Fisher B; Costantino J; Redmond C; Poisson R; Bowman D; Couture J; Dimitrov NV; Wolmark N; Wickerham DL; Fisher ER
    N Engl J Med; 1989 Feb; 320(8):479-84. PubMed ID: 2644532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd.
    Bratherton DG; Brown CH; Buchanan R; Hall V; Kingsley Pillers EM; Wheeler TK; Williams CJ
    Br J Cancer; 1984 Aug; 50(2):199-205. PubMed ID: 6380554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen in axillary node--negative breast cancer: multisystem benefits and risks.
    Love RR
    Cancer Invest; 1992; 10(6):587-93. PubMed ID: 1422894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer.
    Milsted R; Habeshaw T; Kaye S; Sangster G; Macbeth F; Campbell-Ferguson J; Smith D; Calman K
    Cancer Chemother Pharmacol; 1985; 14(3):272-3. PubMed ID: 3888433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.
    Tormey DC; Gray R; Falkson HC
    J Natl Cancer Inst; 1996 Dec; 88(24):1828-33. PubMed ID: 8961972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
    Boccardo F; Rubagotti A; Bruzzi P; Cappellini M; Isola G; Nenci I; Piffanelli A; Scanni A; Sismondi P; Santi L
    J Clin Oncol; 1990 Aug; 8(8):1310-20. PubMed ID: 2199618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.
    Love RR; Newcomb PA; Wiebe DA; Surawicz TS; Jordan VC; Carbone PP; DeMets DL
    J Natl Cancer Inst; 1990 Aug; 82(16):1327-32. PubMed ID: 2199681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.
    Bianco AR; De Placido S; Gallo C; Pagliarulo C; Marinelli A; Petrella G; D'Istria M; Delrio G
    Lancet; 1988 Nov; 2(8620):1095-9. PubMed ID: 2903322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant endocrine therapy of breast cancer--a controlled clinical trial of oestrogen and anti-oestrogen: preliminary results of the Copenhagen breast cancer trials.
    Palshof T; Mouridsen HT; Daehnfeldt JL
    Recent Results Cancer Res; 1980; 71():185-9. PubMed ID: 6988914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Christie hospital adjuvant tamoxifen trial--status at 10 years.
    Ribeiro G; Swindell R
    Br J Cancer; 1988 Jun; 57(6):601-3. PubMed ID: 3044432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms associated with tamoxifen treatment in postmenopausal women.
    Love RR; Cameron L; Connell BL; Leventhal H
    Arch Intern Med; 1991 Sep; 151(9):1842-7. PubMed ID: 1888251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
    Gelber RD
    Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
    [No Abstract]   [Full Text] [Related]  

  • 18. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
    Mouridsen HT; Palshof T; Engelsman E; Sylvester R
    Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
    [No Abstract]   [Full Text] [Related]  

  • 19. Using a population-based cancer registry for recruitment in a pilot cancer control study.
    Newcomb PA; Love RR; Phillips JL; Buckmaster BJ
    Prev Med; 1990 Jan; 19(1):61-5. PubMed ID: 2181434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.
    McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K
    Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.